文献速递乳腺MR

多参数MRI区分乳腺腔面与非腔面亚型

Evaluating the utility of qualitative and quantitative multiparametric magnetic resonance imaging (MRI) parameters in distinguishing luminal and nonluminal breast cancer subtypes.
PubMed 文献 · Clin Radiol · 2026-07-06

前瞻性单中心研究纳入102例乳腺浸润性导管癌患者,行3T多参数MRI,按免疫组化分为腔面与非腔面组。非腔面肿瘤常表现为环形强化、瘤周水肿、较高Ktrans与SER、较低Ve及ADC。瘤周水肿、低Ve和高SER为独立预测因子,三者联合AUC达0.92,敏感度87%、特异度86%。

要点

  • 非腔面乳腺癌更常见环形强化、瘤周水肿及腋窝淋巴结肿大。
  • 瘤周水肿、低Ve和高SER联合可较好提示非腔面亚型。
  • ADC与MRS胆碱峰可作为辅助鉴别参考。

核心结论

  • 多参数MRI有潜力作为无创指标区分乳腺腔面与非腔面癌,辅助个体化治疗与预后判断。
  • 瘤周水肿、低Ve和高SER为预测非腔面亚型的独立因素,联合AUC为0.92。

研究设计与样本

  • 前瞻性单中心研究,共102例新诊断乳腺浸润性导管癌患者。
  • 所有患者行3T多参数MRI,包括T1WI、T2WI、减影图像、DCE-MRI、DWI及MRS。
  • 统计学采用ANOVA、卡方检验、Kruskal-Wallis检验、ROC曲线分析及logistic回归。

关键影像表现/征象

  • 腔面肿瘤常形态不规则、边缘毛刺、不均匀强化。
  • 非腔面肿瘤常表现为边缘清楚、环形强化、瘤周水肿及腋窝淋巴结肿大。
  • 非腔面肿瘤更常出现MRS胆碱峰。

诊断标准与关键数值

  • 多因素回归显示瘤周水肿OR为6.7、低Ve OR为0.032、高SER OR为1.046,均为非腔面亚型独立预测因子。
  • 三者联合的AUC为0.92,95%置信区间原文未提供具体范围。
  • 三者联合的敏感度为87%,特异度为86%。
  • 非腔面肿瘤表现为较高Ktrans、SER及最大上升斜率,较低Ve及ADC值。

临床应用与阅片要点

  • 阅片时观察到环形强化、瘤周水肿提示非腔面乳腺癌可能,报告应主动描述。
  • 结合DCE参数中Ve减低、SER升高可提高对非腔面亚型的判读信心。
  • 该结果尚需外部验证,临床实施前不应替代组织病理诊断。

局限性

  • 原文指出在临床实施前需要外部验证。
  • 本研究为单中心设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: The aim of this study is to evaluate the ability of multiparametric breast magnetic resonance imaging (MRI) parameters to noninvasively distinguish luminal and nonluminal subtypes of invasive ductal carcinoma (IDC).

MATERIALS AND METHODS: This prospective single-centre study included 102 newly diagnosed cases of breast IDC who underwent 3T multiparametric MRI. They were categorised into luminal (A and B subtypes) and nonluminal (HER2-enriched and triple-negative subtypes) groups based on immunohistochemistry. MRI included T1WI, T2WI, subtraction images, dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), and MR spectroscopy (MRS). Morphological, semiquantitative, and quantitative DCE parameters, apparent diffusion coefficient (ADC) values, and the MRS choline peak were studied. Statistical comparisons were performed using analysis of variance (ANOVA), chi-square, Kruskal-Wallis tests, receiver operating characteristic (ROC) curve analysis, and logistic regression.

RESULTS: Forty-eight (47.1%) patients had luminal and 54 (52.9%) had nonluminal tumours. Luminal tumours were usually irregular with spiculated margins and heterogeneous enhancement, while nonluminal tumours showed circumscribed margins, rim enhancement, perilesional oedema, and axillary lymphadenopathy. Nonluminal tumours demonstrated higher Ktrans, signal enhancement ratio (SER), and maximum slope of increase values, lower Ve and ADC values, and a more frequent choline peak. On multivariate regression, perilesional oedema (odds ratio [OR]: 6.7), low Ve (OR: 0.032), and high SER (OR: 1.046) were independent predictors of the nonluminal subtype, and together they achieved an area under the curve (AUC) of 0.92 (confidence interval 95%), with a sensitivity of 87%, and a specificity of 86%.

CONCLUSION: These findings suggest the potential utility of multiparametric MRI in providing noninvasive markers for distinguishing luminal from nonluminal breast cancers, supporting its role as an adjunct to histopathology for personalised treatment and prognostication.; however, external validation is required before clinical implementation.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Mohakud, Pavithra, Naik, et al. Evaluating the utility of qualitative and quantitative multiparametric magnetic resonance imaging (MRI) parameters in distinguishing luminal and nonluminal breast cancer subtypes. Clin Radiol. 2026. PMID: 42526270. doi:10.1016/j.crad.2026.107426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。